Oxford Science Enterprises — 2025 Investments

4 investments dated 2025 · listed companies and verified rows first · show all

Mode Labsmodelabs.tech inMay 2025✓ verified

ModelLabs develops open microcavity sensing technologies for remote environmental monitoring.

AI & Machine LearningCleantechClimate TechDeep TechHardwareQuantum ComputingOxford, GB

Daniel Miles-Barrett(CTO)Prof. Jason Smith(Academic Founder)Dean James(CEO)in

Snowfox Discoverysnowfoxdiscovery.com inJan 2025✓ verified

Snow Fox Discovery explores for and develops natural (geologic) hydrogen resources, aiming to supply low-carbon hydrogen for a net-zero energy transition.

CleantechClimate TechEnergy

Daniel McMahonin

Co-investorsAP Ventures Oxford bp ventures

Scripta Therapeuticsscriptatherapeutics.com inSeed · Nov 2025 · $12M

Scripta Therapeutics is a drug discovery company that maps and modulates transcription factors using AI/ML models and patient-derived disease models to identify novel therapeutics.

AI & Machine LearningBiotechDeep Tech

Co-investorsAlbionVC Apollo Health Ventures

Valink Therapeuticsvalinktx.com inSeries A · Oct 2025

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Arne Scheu(Founder)inIrsyad Khairil(Founder)in

Co-investorsHoxton Ventures LongeVC Metaplanet Oxonian Ventures P53 Invest RV Invest GmbH +9 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.